跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
MONTEK CHEWABLE TABLETS 5MG
Approved
THERAPEUTIC
MONTEK CHEWABLE TABLETS 5MG
Sun Pharmaceutical Industries Limited.
🇸🇬 Health Sciences Authority
Approval Date
Feb 19, 2019
Approval ID
c2db73e88f90175d
Company
Sun Pharmaceutical Industries Limited.
Type
Therapeutic
Approval Details
Approval Id
c2db73e88f90175d
Drug Name
MONTEK CHEWABLE TABLETS 5MG
Product Name
MONTEK CHEWABLE TABLETS 5MG
Approval Number
SIN15631P
Approval Date
2019-02-19
Registrant
RANBAXY (MALAYSIA) SDN. BHD.
Licence Holder
RANBAXY (MALAYSIA) SDN. BHD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, CHEWABLE
Route Of Administration
ORAL
Atc Code
R03DC03
Atc Item Name
montelukast
Pharma Manufacturer Name
RANBAXY (MALAYSIA) SDN. BHD.
Company Detail Path
/organization/ranbaxy-malaysia-sdn-bhd
Active Ingredients
Montelukast Sodium 5.187mg Equivalent to Montelukast
5.00mg
MONTELUKAST SODIUM 5.187 MG EQUIVALENT TO MONTELUKAST
5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 19, 2019
Approval ID
c2db73e88f90175d
Type
Therapeutic
Back to HSA Approvals
MONTEK CHEWABLE TABLETS 5MG - HSA Drug Approval Details